Sunday 21 September 2014
 
»
Tag
 
»
GlaxoSmithKline

Glaxo fined $489m for paying bribes in China

China has fined GlaxoSmithKline (GSK) a record three billion yuan ($489 million) for paying bribes to doctors to use its drugs, underlining the risks of doing business in the country while also ending a damaging chapter for the British drugmaker

More…

Tampering: GSK recalls weight-loss drug Alli in US

GlaxoSmithKline is recalling all supplies of its non-prescription weight-loss drug Alli in the US and Puerto Rico after customers reported finding other pills and tablets in some bottles. The news is a fresh blow for a product onc

More…

Production snag hits chickenpox vaccine delivery

GlaxoSmithKline has stopped worldwide deliveries of two chickenpox vaccines for children after discovering that some batches produced at its factory in Wavre, Belgium, were not up to standard. Britain's biggest drugmaker, whic

More…

GSK diabetes drug set for EU approval

GlaxoSmithKline said European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan. Albiglutide belongs to the same class of injectable GLP-1 drugs as Victoza from Nov

More…

GSK heart drug misses goal in major study

An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major late-stage clinical study, dealing a blow to one of the company's biggest new treatment hopes. Darapla

More…

China launches crackdown on pharmaceutical sector

China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from a bribery scandal at British drugmaker GlaxoSmithKline.

More…

GSK used travel agencies for China bribes: police'

Chinese police on Monday accused British drugmaker GlaxoSmithKline of channelling bribes to Chinese officials and doctors through travel agencies for six years to illegally boost sales and to raise the price of its medicines in the country.

More…

GlaxoSmithKline bets on 'electroceuticals'

  GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body.   The company said on Wednesda

More…

GlaxoSmithKline wins US approval for new vaccine

US health regulators have approved a new four-strain seasonal influenza vaccine made by GlaxoSmithKline, the company said. The US Food and Drug Administration has approved Fluarix Quadrivalent to immunise children age 3 and older

More…

Malaria vaccine disappoints in trial

  A GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa's largest ever clinical trial. &n

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads